Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 156,079 229,843 273,203 611,547
Total Sell Value $13,472,349 $20,340,408 $24,241,430 $58,103,504
Total People Sold 5 5 6 7
Total Sell Transactions 13 19 25 55
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 1281
  Page 30 of 52  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2010-11-24 4 OE $14.39 $161,888 D/D 11,250 38,060     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-11-23 4 S $27.02 $27,021 D/D (1,000) 93,567     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-11-23 4 OE $6.46 $6,460 D/D 1,000 94,567     -
   Wood Mark VP, Human Resources   •       –      –    2010-11-22 4 S $26.60 $65,933 D/D (2,479) 14,243     -
   Wood Mark VP, Human Resources   •       –      –    2010-11-22 4 OE $14.39 $40,422 D/D 2,479 16,722     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-11-18 4 S $25.99 $25,988 D/D (1,000) 93,567     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-11-18 4 OE $6.46 $6,460 D/D 1,000 94,567     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-11-18 4 S $25.87 $811,546 D/D (31,375) 29,881     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-11-18 4 OE $14.39 $451,486 D/D 31,375 61,756     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-11-17 4 S $25.80 $12,900 D/D (500) 61,256     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-11-17 4 OE $14.39 $7,195 D/D 500 30,381     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-11-17 4 S $25.75 $206,000 D/D (8,000) 29,881     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-11-08 4 S $25.78 $51,569 D/D (2,000) 93,567     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-11-08 4 OE $6.46 $12,920 D/D 2,000 95,567     -
   Davis George Eric SVP, General Counsel   •       –      –    2010-11-04 4 S $25.83 $267,921 D/D (10,371) 27,901     -
   Davis George Eric SVP, General Counsel   •       –      –    2010-11-04 4 OE $11.74 $117,400 D/D 10,000 38,272     -
   Baffi Robert EVP, Technical Operations   •       –      –    2010-11-03 4 S $25.24 $50,488 D/D (2,000) 67,713     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-11-03 4 S $25.46 $101,824 D/D (4,000) 93,567     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-11-03 4 OE $6.46 $25,840 D/D 4,000 97,567     -
   Baffi Robert EVP, Technical Operations   •       –      –    2010-11-02 4 GA $0.00 $0 I/I 473 2,702     -
   Baffi Robert EVP, Technical Operations   •       –      –    2010-11-02 4 GD $0.00 $0 D/D 473 57,886     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-11-02 4 S $25.64 $89,750 D/D (3,500) 93,567     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-11-02 4 OE $6.46 $12,920 D/D 2,000 97,067     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-11-01 4 S $25.75 $62,721 D/D (2,435) 31,000     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-11-01 4 OE $11.05 $9,205 D/D 833 33,435     -
  1281 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 30 of 52
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us